Biocon Pharma Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Special Economic Zone, Block F1, Plot No.5, Phase IV, Bommasandra - Jigani Link Road, Bommasandra Post, Bengaluru, Karnataka 560099, India (IND)
- Operations here
- analysismanufacturepackrepack
- FDA identifiers
- FEI 3013637926 · DUNS 871412155
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-06-02
Drugs this plant is listed as making
14 distinct drugs across 51 products name this site in their FDA label.
- atorvastatin calciumBiocon Pharma Inc.
- DapagliflozinBiocon Pharma Inc.
- dasatinibBluePoint Laboratories
- everolimusNorthStar RxLLC
- FingolimodBiocon Pharma Inc.
- Mycophenolic AcidBiocon Pharma Inc.
- PosaconazoleBiocon Phama Inc.
- Rosuvastatin calciumBiocon Pharma Inc
- Sacubitril and ValsartanBiocon Pharma Inc.
- TacrolimusBiocon Pharma Inc.
- TeriflunomideBiocon Pharma Inc.
- TofacitinibBiocon Pharma Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.